However, current biomarkers include PD-1/PD-L1 expression levels, microsatellite instability (MSI), tumor mutation burden (TMB), and Epstein–Barr virus (EBV) infection status were still some limitations (11, 12, 32). Here, CD274 is linked to neoplasm.